Medtronic launches mySentry remote glucose monitor
17 January 2012
Minneapolis, USA. Medtronic, Inc. (NYSE:MDT) has announced FDA
approval and US market launch of its mySentry remote glucose monitor.
The monitor is aimed at home use to allow a parent or caregiver to
monitor from another room a patient’s MiniMed Paradigm REAL-Time
Revel System. The remote glucose monitor also marks the launch of a
new category of connected care solutions that will provide people
with diabetes and their caregivers convenient options to access
their diabetes management information.
mySentry allows caregivers to see real-time insulin pump status
and glucose trends, as well as hear alerts and alarms, at their
bedside while an adult or child with diabetes sleeps in their own
room. This could be especially useful for parents, who could be
alerted through a predictive alarm in the middle of the night if
their child’s glucose levels are falling, allowing them to take
action to prevent an episode of low blood sugar (hypoglycemia). For
a caregiver of someone with type 1 diabetes, night time hypoglycemia
(low blood sugar) represents one of their greatest concerns.
The Medtronic mySentry remote glucose monitor
“Many of the parents of our patients wake up a couple of times
every night to check their child’s blood sugar level and even that
may not be enough to prevent episodes of severe hypoglycemia,” said
William Tamborlane, M.D., Chief of Pediatric Endocrinology and
Deputy Director of the Yale Center for Clinical Investigation.
“Advances in continuous glucose monitoring, including remote
monitoring like mySentry, have given parents an added level of
protection from dangerous nighttime hypoglycemia occurring in their
sleeping child, as well as a means to improve their quality of
An estimated 75% of all episodes of severe hypoglycemia in
children occur at night. By alerting a parent or caregiver to an
alarm, mySentry may provide added night time protection.
“We’re excited to bring this new innovation to market that could
give caregivers greater peace of mind. The mySentry Remote Glucose
Monitor is the first step toward our vision to develop an entire
category of Connected Care products that help people more
proactively manage their diabetes by making it easier and more
convenient to access the wealth of information captured by our
integrated insulin pump and continuous glucose monitoring (CGM)
system,” said Greg Meehan, Vice President and General Manager of the
Continuous Glucose Monitoring business at Medtronic.
mySentry is used in conjunction with the MiniMed Paradigm
REAL-Time Revel System, an insulin pump with built-in continuous
glucose monitoring. mySentry can be placed in the bedroom or in any
room throughout the house so all important information is just a
glance away. mySentry provides flexibility and a wide range of uses
including displaying all of the alerts and alarms available on the
Paradigm Revel insulin pump: predictive alerts, continuous glucose
monitoring (CGM) graph, insulin pump battery life, amount of insulin
remaining, and time until the next glucose sensor calibration.